The expression of ADAM17 has not been determined in COPD macrophages compared to controls, but there is evidence for increased numbers of cells (presumably immune cells) positive for ADAM17 phosphorylation at 735-threonine (and hence increased activation) in the alveolar spaces of COPD patients with emphysema compared to controls [32]. Here, ADAM17 is linked to chronic obstructive pulmonary disease.